Aimmune Presents European Phase III PALISADE Screening Data At 2017 European Academy of Allergology and Clinical Immunology (EAACI) Congress Post author:Sam Post published:June 19, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Why 90% of This $26 Billion Biotech's Sales Could be At Risk Within the Next 2 Years April 20, 2017 Accuray Inc. Release: First Radixact System Research Results Presented At The August 3, 2017 Roche Faces Off With Itself for $9 Billion Breast Cancer Drug Business February 13, 2017